SAMHD1: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== SAMHD1 == | |||
'''SAMHD1''' | '''SAMHD1''' is a protein encoded by the '''SAMHD1 gene''' in humans. It is a member of the HD domain superfamily and is involved in the regulation of the innate immune response. SAMHD1 is known for its role in restricting the replication of [[HIV-1]] in certain immune cells, such as [[dendritic cells]], [[macrophages]], and [[resting CD4+ T cells]]. | ||
== | == Function == | ||
SAMHD1 functions as a deoxynucleotide triphosphohydrolase (dNTPase), which means it hydrolyzes deoxynucleotide triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphate. This activity reduces the intracellular pool of dNTPs, which are the building blocks for [[DNA synthesis]]. By depleting dNTPs, SAMHD1 limits the ability of [[retroviruses]] like HIV-1 to synthesize DNA and replicate within host cells. | |||
SAMHD1 | |||
=== | == Clinical Significance == | ||
Mutations in the SAMHD1 gene have been associated with [[Aicardi-Goutières syndrome]], a rare genetic disorder that mimics [[congenital viral infection]] and is characterized by [[encephalopathy]], [[skin lesions]], and [[autoimmune]] phenomena. SAMHD1 mutations can lead to an accumulation of [[nucleic acids]] in cells, triggering an inappropriate immune response. | |||
Mutations in the SAMHD1 gene have been associated with Aicardi-Goutières syndrome | |||
==Research | == Research == | ||
==Also | Research into SAMHD1 has expanded our understanding of its role in [[viral restriction]] and [[immune regulation]]. Studies have shown that SAMHD1 is involved in the response to [[DNA damage]] and may play a role in [[cancer]] biology. The protein's ability to regulate dNTP levels makes it a potential target for therapeutic interventions in diseases where dNTP balance is disrupted. | ||
* [[HIV-1]] | |||
== See Also == | |||
* [[HIV-1 restriction factors]] | |||
* [[Innate immune system]] | |||
* [[Aicardi-Goutières syndrome]] | * [[Aicardi-Goutières syndrome]] | ||
== References == | |||
<references/> | |||
{{Protein-stub}} | {{Protein-stub}} | ||
{{ | {{Viral-stub}} | ||
[[Category:Proteins]] | [[Category:Proteins]] | ||
[[Category:Human genes]] | |||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Virology]] | [[Category:Virology]] | ||
Latest revision as of 20:45, 30 December 2024
SAMHD1[edit]
SAMHD1 is a protein encoded by the SAMHD1 gene in humans. It is a member of the HD domain superfamily and is involved in the regulation of the innate immune response. SAMHD1 is known for its role in restricting the replication of HIV-1 in certain immune cells, such as dendritic cells, macrophages, and resting CD4+ T cells.
Function[edit]
SAMHD1 functions as a deoxynucleotide triphosphohydrolase (dNTPase), which means it hydrolyzes deoxynucleotide triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphate. This activity reduces the intracellular pool of dNTPs, which are the building blocks for DNA synthesis. By depleting dNTPs, SAMHD1 limits the ability of retroviruses like HIV-1 to synthesize DNA and replicate within host cells.
Clinical Significance[edit]
Mutations in the SAMHD1 gene have been associated with Aicardi-Goutières syndrome, a rare genetic disorder that mimics congenital viral infection and is characterized by encephalopathy, skin lesions, and autoimmune phenomena. SAMHD1 mutations can lead to an accumulation of nucleic acids in cells, triggering an inappropriate immune response.
Research[edit]
Research into SAMHD1 has expanded our understanding of its role in viral restriction and immune regulation. Studies have shown that SAMHD1 is involved in the response to DNA damage and may play a role in cancer biology. The protein's ability to regulate dNTP levels makes it a potential target for therapeutic interventions in diseases where dNTP balance is disrupted.
See Also[edit]
References[edit]
<references/>
